Back to All Resources

Buprenorphine-Naloxone Treatment for Opioid Use Disorder

Posted June 17, 2020

Buprenorphine-Naloxone Treatment for Opioid Use Disorder

Centre for Addiction and Mental Health (CAMH) Click to view files

CPSA's 2022 annual report is now available

See highlights from the past year and read accompanying stories online.